Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Oris Tandlægerne Sæby I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5%   Bankruptcy risk   4.9% 5.5% 7.7% 4.7% 5.1% 4.6% 12.2% 10.0%   Credit score (0-100)   46 43 32 44 43 45 19 25   Credit rating   BBB BBB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   7,114 8,570 9,059 11,381 10,472 10,377 0.0 0.0   EBITDA   2,255 2,388 257 1,832 2,560 2,712 0.0 0.0   EBIT   2,255 2,388 257 1,832 2,560 2,712 0.0 0.0   Pre-tax profit (PTP)   2,254.7 2,386.2 249.2 1,826.7 2,548.6 2,691.7 0.0 0.0   Net earnings   2,254.7 2,386.2 249.2 1,826.7 2,548.6 2,691.7 0.0 0.0   Pre-tax profit without non-rec. items   2,255 2,386 249 1,827 2,549 2,692 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,017 801 84.0 1,661 1,228 1,532 1,532 1,532   Interest-bearing liabilities   346 384 441 15.0 30.7 89.6 0.0 0.0   Balance sheet total (assets)   2,682 2,856 3,672 3,881 2,986 3,123 1,532 1,532   Net Debt   336 382 437 0.7 4.5 67.2 -1,532 -1,532     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   7,114 8,570 9,059 11,381 10,472 10,377 0.0 0.0   Gross profit growth   2.5% 20.5% 5.7% 25.6% -8.0% -0.9% -100.0% 0.0%   Employees   10 10 10 17 15 15 0 0   Employee growth %   11.1% 0.0% 0.0% 70.0% -11.8% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,682 2,856 3,672 3,881 2,986 3,123 1,532 1,532   Balance sheet change%   -8.8% 6.5% 28.6% 5.7% -23.1% 4.6% -50.9% 0.0%   Added value   2,255.2 2,388.3 257.4 1,831.8 2,559.8 2,712.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   31.7% 27.9% 2.8% 16.1% 24.4% 26.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   80.2% 86.2% 7.9% 48.5% 74.6% 88.8% 0.0% 0.0%   ROI %   128.7% 187.5% 30.1% 166.4% 174.4% 188.3% 0.0% 0.0%   ROE %   159.1% 262.5% 56.3% 209.3% 176.4% 195.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   37.9% 28.0% 2.3% 42.8% 41.1% 49.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   14.9% 16.0% 169.8% 0.0% 0.2% 2.5% 0.0% 0.0%   Gearing %   34.0% 47.9% 524.8% 0.9% 2.5% 5.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.6% 2.0% 2.2% 49.1% 34.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.5 1.5 1.1 2.1 2.2 2.7 0.0 0.0   Current Ratio   1.6 1.5 1.2 2.2 2.3 2.9 0.0 0.0   Cash and cash equivalent   10.0 2.1 3.6 14.3 26.2 22.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,016.8 987.7 550.9 2,128.4 1,706.0 2,030.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   226 239 26 108 171 181 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   226 239 26 108 171 181 0 0   EBIT / employee   226 239 26 108 171 181 0 0   Net earnings / employee   225 239 25 107 170 179 0 0